Psych Vivas · Specialty psychiatry — sexual dysfunction and paraphilias
Sexual dysfunction and paraphilias — structured clinical viva
Fellowship viva spanning PDE5–nitrate contraindication, SSRI sexual SE, pedophilic interest vs disorder, and child-protection ethics.
On this page & tools
Target exams
Interpretation
Reveal interpretation
Father — ED and nitrates. Sildenafil has strong efficacy evidence for ED but is contraindicated with concurrent nitrates because of severe hypotension risk. Do not prescribe PDE5 inhibitors while he remains on isosorbide mononitrate. Coordinate with cardiology/GP on anti-anginal regimen suitability before any PDE5 trial; address diabetes, vascular risk, alcohol, and relationship factors. Psychogenic-only assumptions are unsafe in a diabetic midlife man.[1]
Partner — paroxetine anorgasmia. Classic serotonergic sexual side-effect. Options: validate, consider dose timing/adjustment if panic/depression allows, switch to a relatively lower-risk antidepressant, or specialist strategies. Separate panic efficacy from sexual tolerability in shared decision-making.[2][6]
Son — pedophilic interest disclosure. Ego-dystonic interest in prepubescent children with help-seeking is clinically serious. Pedophilic disorder requires the interest plus acted urges with children and/or marked distress/interpersonal difficulty — distress is present; offence status needs careful assessment (including online material). Interest ≠ inevitable offending (motivation–facilitation model), but risk assessment and child-protection duties dominate. “Chemical castration” online is not a DIY plan: antiandrogen/GnRH pathways are specialist, consent-based, monitored (WFSBP), and never replace reporting duties or psychological risk work if indicated. Arrange urgent psychiatric/forensic assessment; do not ignore an email disclosure.[3][4][5]
Key points
[1] [2] [3]References
- [1]Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group N Engl J Med, 1998.PMID 9580646
- [2]Montejo AL, Llorca G, Izquierdo JA, et al. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients J Clin Psychiatry, 2001.PMID 11229449
- [3]Thibaut F, Cosyns P, Fedoroff JP, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) 2020 guidelines for the pharmacological treatment of paraphilic disorders World J Biol Psychiatry, 2020.PMID 32452729
- [4]Seto MC The Motivation-Facilitation Model of Sexual Offending Sex Abuse, 2019.PMID 28715948
- [5]Krueger RB, Reed GM, First MB, et al. Proposals for Paraphilic Disorders in the International Classification of Diseases and Related Health Problems, Eleventh Revision (ICD-11) Arch Sex Behav, 2017.PMID 28210933
- [6]Clayton AH, El Haddad S, Iluonakhamhe JP, et al. Sexual dysfunction associated with major depressive disorder and antidepressant treatment Expert Opin Drug Saf, 2014.PMID 25148932